Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

NCT05802836 is registered in ClinicalTrials.gov with Christoph Königs as lead sponsor.

NCT NCT05802836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05802836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
Lead sponsor
Christoph Königs
Phase
Observational
Overall status
Recruiting
Start date
April 26, 2023
Completion date
December 31, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe hemophilia a, severe hemophilia a with inhibitor, severe hemophilia a without inhibitor